Jade Biosciences, Inc. (JBIO) Misses Q2 EPS by 55c

Jade Biosciences, Inc. (NASDAQ: JBIO) reported Q2 EPS of ($0.86), $0.55 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Jade Biosciences, Inc. (JBIO) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Quantum BioPharma gets FDA clearance for MS drug phase 2 trial
• Click Holdings CEO purchases ~$49,900 in company shares on open market